P-selectin molecules are present on the surface of activated platelets and vascular endothelial cells and have been linked to sickle cell vaso-occlusive crises.
Crizanlizumab
Brolucizumab
Tildrakizumab
Risankizumab
Reslizumab
Mogamulizumab
Inebilizumab
Etaracizumab